Agnes M Rimando Selected Research

Agnes M Rimando Research Topics

Disease

20	Neoplasms (Cancer) 01/2018 - 06/2002
9	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 03/2010
6	Colonic Neoplasms (Colon Cancer) 12/2010 - 01/2007
5	Body Weight (Weight, Body) 01/2017 - 01/2007
4	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2013
4	Carcinogenesis 09/2012 - 01/2007
4	Inflammation (Inflammations) 02/2012 - 02/2008
3	Insulin Resistance 01/2017 - 10/2008
3	Obesity 01/2017 - 09/2012
3	Aberrant Crypt Foci 07/2010 - 01/2007
2	Hyperglycemia 01/2017 - 09/2012
2	Glioma (Gliomas) 05/2012 - 01/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Cognitive Dysfunction 07/2014
1	Growth Disorders 07/2014
1	Anxiety Disorders (Anxiety Disorder) 06/2013
1	Adenocarcinoma 07/2010
1	Hemolysis 03/2010
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Colitis 02/2008
1	Weight Loss (Weight Reduction) 05/2007

Drug/Important Bio-Agent (IBA)

17	pterostilbeneIBA 01/2018 - 06/2002
16	ResveratrolIBA 01/2018 - 06/2002
10	StilbenesIBA 11/2017 - 07/2004
7	Proteins (Proteins, Gene)FDA Link 11/2017 - 09/2010
4	CholesterolIBA 01/2018 - 10/2008
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 09/2012
3	AntioxidantsIBA 01/2018 - 06/2002
3	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2015
3	Biological ProductsIBA 08/2015 - 10/2008
2	3,3',4,5'-tetrahydroxystilbeneIBA 01/2017 - 08/2013
2	Blood Glucose (Blood Sugar)IBA 01/2017 - 09/2012
2	CarbohydratesIBA 01/2017 - 09/2012
2	GlucosidasesIBA 01/2017 - 09/2012
2	PolyphenolsIBA 01/2017 - 08/2013
2	AndrogensIBA 01/2016 - 03/2010
2	LipidsIBA 07/2014 - 04/2010
2	CytokinesIBA 08/2013 - 07/2009
2	XenobioticsIBA 09/2012 - 08/2008
2	FlavonoidsIBA 05/2012 - 01/2009
2	LipopolysaccharidesIBA 02/2012 - 07/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2012 - 07/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2010 - 07/2010
2	AzoxymethaneIBA 07/2010 - 01/2007
1	Histone Deacetylase InhibitorsIBA 11/2017
1	Vorinostat FDA Link 11/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2017
1	Hormones (Hormone)IBA 11/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Sucrose (Saccharose)IBA 01/2017
1	TensinsIBA 01/2017
1	Starch (Cornstarch)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Acarbose FDA LinkGeneric 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Messenger RNA (mRNA)IBA 09/2015
1	ChromatinIBA 08/2015
1	CalciumIBA 07/2014
1	Nucleic AcidsIBA 07/2014
1	Pharmaceutical PreparationsIBA 06/2013
1	Co-Repressor ProteinsIBA 01/2013
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 01/2013
1	Nucleosomes (Nucleosome)IBA 01/2013
1	EnzymesIBA 09/2012
1	VaccinesIBA 05/2012
1	wogoninIBA 05/2012
1	NitritesIBA 02/2012
1	RetinoidsIBA 12/2010
1	ChalconesIBA 12/2010
1	Chalcone (Benzalacetophenone)IBA 12/2010
1	Cyclin-Dependent Kinase Inhibitor p27IBA 09/2010
1	NF-kappa B (NF-kB)IBA 07/2010
1	Cyclin D1IBA 07/2010
1	beta CateninIBA 07/2010
1	Bile Acids and Salts (Bile Acids)IBA 04/2010
1	Ethanol (Ethyl Alcohol)IBA 04/2010
1	microcrystalline celluloseIBA 04/2010
1	3,5-dihydroxy-4'-methoxystilbeneIBA 03/2010
1	Glutathione (Reduced Glutathione)IBA 03/2010
1	pinostilbeneIBA 03/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2009
1	EndotoxinsIBA 07/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	p38 Mitogen-Activated Protein KinasesIBA 07/2009
1	PhytochemicalsIBA 10/2008
1	Prostaglandins EIBA 02/2008
1	ChlorophyllIBA 05/2007
1	Glyphosate (Roundup)IBA 05/2007

Therapy/Procedure

1	Chemoprevention 08/2013
1	Immunotherapy 05/2012
1	Therapeutics 01/2009